Recent Trends in COPD Prevalence in Spain: A Repeated Cross-Sectional Survey 1997 to 2007.

Soriano, JB; Ancochea, Julio; Miravitlles, Marc; Garcia-Rio, FF; Durán, Estela Liliana; Muñoz, Lyda; Fueyo, Arturo; Sobradillo-Peña, Víctor

doi:10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4527

Cited by 25 publications

(40 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Women reportedly suffer a delay in the diagnosis of COPD, explainable in part by voluntary postponement of access to a consultation or in some patients by the prevalence of symptoms of fatigue or depression that point to a different type of treatment [16]. Allowing for these reservations, the prevalence of COPD is currently estimated, depending on the country, to range from 4.5% to 10.2% [17,18]. Although a 2006 meta-analysis assessed prevalence at 9.8% among men and 5.6% among women [19], the latest data mitigate this difference.…”

Section: Epidemiology Of Copd In Womenmentioning

confidence: 99%

Women and COPD: do we need more evidence?

et al. 2019

View full text Add to dashboard Cite

@ERSpublicationsThe face of COPD is increasingly female. We need more evidence and a change in how the disease is managed.ABSTRACT The increasingly female face of chronic obstructive pulmonary disease (COPD) prevalence among women has equalled that of men since 2008, due in part to increased tobacco use among women worldwide and exposure to biomass fuels. This finding is supported by a number of characteristics. There is evidence of susceptibility to smoking and other airborne contaminants, along with epidemiological and phenotypic manifestations. COPD has thus become the leading cause of death in women in the USA. The clinical presentation is characterised by increasingly pronounced dyspnoea with a marked tendency towards anxiety and depression, undernutrition, nonsmall cell lung cancer (especially adenocarcinoma) and osteoporosis. Quality of life is also more significantly impacted. The theories advanced to explain these differences involve the role played by oestrogens, impaired gas exchange in the lungs and smoking habits. While these differences require appropriate therapeutic responses (smoking cessation, pulmonary rehabilitation, long-term oxygen therapy), barriers to the treatment of women with COPD include greater under-diagnosis than in men, fewer spirometry tests and medical consultations. Faced with this serious public health problem, we need to update and adapt our knowledge to the epidemiological changes.

show abstract

Section: Epidemiology Of Copd In Womenmentioning

confidence: 99%

Women and COPD: do we need more evidence?

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Over the past two decades varying estimates of COPD prevalence have been presented [8e10,12e15, 18,19]. In ages >40 years the prevalence of COPD ranged from 10% to more than 25% between the Burden of Obstructive Lung Disease (BOLD) study centers [20] using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) [3] criterion FEV 1 /FVC < 0.7 of COPD.…”

Section: Introductionmentioning

confidence: 99%

Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden

Bäckman

Eriksson

Rönmark

et al. 2016

Respiratory Medicine

View full text Add to dashboard Cite

show abstract

“…Chronic obstructive pulmonary disease (COPD) is a common cause of morbidity and mortality worldwide . Population‐based studies report an overall COPD prevalence of 10% . In Latin America, the PLATINO (the Latin American Project for Investigation of Obstructive Lung Disease) study showed a prevalence of 14.3%, and an under‐diagnosis of 89% .…”

Section: Introductionmentioning

confidence: 99%

Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study

Varela

Gómez-Rey

et al. 2016

Respirology

View full text Add to dashboard Cite

Background and objective: Opportunistic chronic obstructive pulmonary disease (COPD) case finding approaches for high-risk individuals with or without symptoms is a feasible option for disease identification. PUMA is an opportunistic case finding study conducted in primary care setting of Argentina, Colombia, Venezuela and Uruguay. The objectives were to measure COPD prevalence in an at-risk population visiting primary care for any reason, to assess the yield of this opportunistic approach and the accuracy of a score developed to detect COPD. Methods: Subjects attending routine primary care visits, ≥40 years of age, current or former smokers or exposed to biomass smoke, completed a questionnaire and performed spirometry. COPD was defined as post-bronchodilator (post-BD) forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) < 0.70 and the lower limit of normal of FEV 1 /FVC. Results: A total of 1743 subjects completed the interview; 1540 performed acceptable spirometry. COPD prevalence was 20.1% (n = 309; ranging from 11.0% in Venezuela to 29.6% in Argentina) when defined using post-BD FEV 1 /FVC < 0.70, and 14.7% (n = 226; ranging from 8.3% in Venezuela to 21.8% in Colombia) using the lower limit of normal. Logistic regression analysis for both definitions showed that the risk of COPD was significantly higher for persons >50 years, heavy smokers (>30 pack-years), with dyspnoea, and having prior spirometry. A simple score and a weighted score constructed using the following predictive factors: gender, age, pack-years smoking, dyspnoea, sputum, cough and spirometry, had a mean accuracy for detecting COPD (post-BD FEV 1 /FVC < 0.70) of 76% and 79% for the simple and weighted scores, respectively. Conclusion: This simple seven-item score is an accurate screening tool to select subjects for spirometry in primary care.

show abstract

Recent Trends in COPD Prevalence in Spain: A Repeated Cross-Sectional Survey 1997 to 2007.

Cited by 25 publications

References 0 publications

Women and COPD: do we need more evidence?

Women and COPD: do we need more evidence?

Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden

Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study

Contact Info

Product

Resources

About